Veru
VERU
#10391
Rank
NZ$61.84 M
Marketcap
NZ$3.85
Share price
-2.19%
Change (1 day)
-56.71%
Change (1 year)

Earnings for Veru (VERU)

Earnings in 2026 (TTM): -NZ$47.96 Million

According to Veru's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$51.86 Million, an increase over its 2024 earnings that were of -NZ$66.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Veru from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$47.96 Million-7.52%
2025 -NZ$51.86 Million-21.84%
2024 -NZ$66.35 Million-49.67%
2023 -NZ$0.14 Billion-31.87%
2022 -NZ$0.2 Billion673.72%
2021 -NZ$25.01 Million-375.47%
2020 NZ$9.07 M-157.74%
2019 -NZ$15.73 Million-32.09%
2018 -NZ$23.15 Million1.17%
2017 -NZ$22.89 Million-1349.01%
2016 NZ$1.83 M-85.97%
2015 NZ$13.05 M99.18%
2014 NZ$6.55 M-51.18%
2013 NZ$13.43 M-33.9%
2012 NZ$20.31 M108.3%
2011 NZ$9.75 M3.75%
2010 NZ$9.4 M-20.61%
2009 NZ$11.84 M136.88%
2008 NZ$4.99 M
2006 -NZ$0.14 Million26.36%
2005 -NZ$0.11 Million
2000 -NZ$3.79 Million
1998 -NZ$5.1 Million-37.72%
1997 -NZ$8.19 Million-47.64%
1996 -NZ$15.64 Million37.12%
1995 -NZ$11.41 Million-15.38%
1994 -NZ$13.48 Million875%
1993 -NZ$1.39 Million-50%
1992 -NZ$2.77 Million-0%
1991 -NZ$2.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.4 Billion 713.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.38 Million-35.46%๐Ÿ‡บ๐Ÿ‡ธ USA